Vivos Therapeutics, Inc.

VVOS·NASDAQ·$0.65Share Price as of 11/2·$4MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/20/26 10-KFY 202504/15/26 10-QQ3 ended 09/30/2511/19/25 10-QQ2 ended 06/30/2508/19/25

Disclosures

8-KCurrent report10/21/26 8-KCurrent report10/19/26 8-KCurrent report10/15/26 8-KCurrent report10/01/26 8-KCurrent report09/08/26

Prospectuses and Registrations

424B3Prospectus05/08/26 S-3/AShelf registration (amended)04/30/26 S-3Shelf registration02/17/26 424B3Prospectus01/14/26 POS AMPost-effective amendment01/02/26

Proxies

DEFA14AAdditional proxy materials11/02/26 DEF 14ADefinitive proxy10/29/26 PRER14APreliminary proxy (revised)10/21/26 PRE 14APreliminary proxy10/19/26 DEF 14ADefinitive proxy09/29/25

Ownership

Form 4Insider transaction10/27/26 Form 4Insider transaction10/26/26 Form 4Insider transaction10/26/26 Form 4Insider transaction09/18/26 Form 4Insider transaction09/18/26

Other

NT 10-QLate filing notification (10-Q)05/15/26 EFFECTRequest for effectiveness05/08/26 CORRESPCorrespondence with the SEC05/06/26 NT 10-KLate filing notification (10-K)03/31/26 UPLOADLetter from the SEC02/23/26